Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis (Q36092555)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

natural killer cell leukemia

1 reference

based on heuristic

inferred from title

author name string

Yi Li

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jia Wei

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Xia Mao

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Qingping Gao

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Longlong Liu

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Ping Cheng

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Limei Liu

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Xinhua Zhang

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Ke Zhang

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jin Wang

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Li Zhu

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jianfeng Zhou

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Yicheng Zhang

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Li Meng

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hanying Sun

15

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Dengju Li

16

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Mei Huang

17

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Wei Huang

18

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jinniu Deng

19

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Donghua Zhang

20

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

2 August 2016

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

e0158827

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution 4.0 International

2 August 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Human natural killer cells: origin, receptors, function, and clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Role for early-differentiated natural killer cells in infectious mononucleosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Six cases of aggressive natural killer-cell leukemia in a Chinese population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Effects of Peptide on NK cell-mediated MHC I recognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

The pathogenesis and treatment of large granular lymphocyte leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Signatures of human NK cell development and terminal differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Aggressive natural killer-cell leukemia with jaundice and spontaneous splenic rupture: a case report and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Adult aggressive natural killer cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Three cases of aggressive natural killer cell leukemia with a lethal hemorrhagic complication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Somatic STAT3 mutations in large granular lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

CD56bright natural killer (NK) cells: an important NK cell subset.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Human natural killer cell development and biology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Aggressive Natural Killer-Cell Leukemia: report of five cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Aggressive natural killer cell leukemia in an adult with establishment of an NK cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 October 2017

Influence of KIR gene copy number on natural killer cell education

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 July 2018

Frequent CD7 antigen loss in aggressive natural killer-cell leukemia: a useful diagnostic marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

2 July 2018

Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Abnormal immunophenotype provides a key diagnostic marker: a report of 29 cases of de novo aggressive natural killer cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Aggressive natural killer cell leukemia: is Epstein-Barr virus negativity an indicator of a favorable prognosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Chemokine system and tissue infiltration in aggressive NK-cell leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

NK-cell neoplasms in Japan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Aggressive natural killer cell leukemia: clinical features and treatment outcome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

23 September 2018

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0158827

21 January 2018

Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4970793

21 October 2018

Fas Ligand–Mediated Lethal Hepatitis After Rapid Lysis of a Localized Natural Killer Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0158827

21 January 2018

Significance of chemokine receptor expression in aggressive NK cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

F-18 FDG PET/CT findings of aggressive NK-cell leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promising approach for aggressive NK cell leukaemia with allogeneic haematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27483437

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0158827

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

2016PLoSO..1158827L

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36092555&oldid=1851226428"